SARS-CoV-2 Rapid Antigen Test Kit Professional Use (GICA)

Product Information:

Feature of KISSH Antigen Test

• 2-steps easy to operate
• High Sensitivity recognized by HS EU Common List
• Quick result within 15mins
• All necessary consumables included
• Based on immunoassay
• More practical than PCR test

Theory

This kit is used for in vitro qualitative detection of nucleocapsid(N) protein antigen from SARS-CoV-2 in human nasal (anterior) swab.

This kit is authorized for home use with self-collected observed direct nasal (anterior) swab from individuals aged 15 years or older or adult collected nasal (anterior) swab from individuals aged four years or older.

Guide for Use

Interpretation

Shenzhen Kisshealh Biotechnology Co., Ltd., located in the Pingshan District, Shenzhen, P.R. China. is a diagnostics company focused on the development and manufacture of IVD tests at the Point-of-Care with highly innovative proprietary technology.

We focused on the emerging markets of in vitro pathological diagnosis and immunodiagnosis. We developed, manufactured and successfully launched the in vitro immunodiagnosis platform for cancer and the POCT for infectious, genetic and chronic diseases.

<span style="color: rgb(33, 33, 33); text-transform: none; text-indent: 0px; letter-spacing: normal;" initial;"="" initial;="" 0px;="" normal;="" 255);="" 255,="" rgb(255,="" 2;="" !important;="" inline="" none;="" 600;="" 14px;="" sans-serif;="" arial,="" roboto,="" w3",="" gb="" sans="" "hiragino="" gb",="" hei",="" micro="" "wenquanyi="" sans",="" "droid="" arimo,="" freesans,="" yahei",="" "microsoft="" helvetica,="" grande",="" "lucida="" ui",="" segoe="">At Kissh we work every day to shape the future of in-vitro diagnostic testing. And our people are our best asset, the reason for our track record and our strength while we are moving forward. We live by our fundamental values and incorporate them in everything that we do. Our best asset is ‘Step Forward Every Second’